Barclays Upgrades Deciphera Pharmaceuticals to Equalweight From Underweight, Price Target Is $26
MT NewswiresApr 30 19:10
Deciphera Pharmaceuticals (DCPH) Was Downgraded to a Hold Rating at JMP Securities
TipRanksApr 30 03:15
JonesTrading: Deciphera Pharmaceuticals (DCPH.US) rating downgraded from buy to hold, with a target price of $25.60.
Zhitong FinanceApr 29 23:20
Jefferies Downgrades Deciphera Pharmaceuticals to Hold, Lowers Price Target to $25.6
BenzingaApr 29 23:15
Deciphera Pharmaceuticals Analyst Ratings
BenzingaApr 29 23:12
Deciphera Pharmaceuticals Acquisition by Ono: A Hold Rating Amidst Prospects and Challenges
TipRanksApr 29 22:25
Piper Sandler Sticks to Their Buy Rating for Deciphera Pharmaceuticals (DCPH)
TipRanksApr 22 20:32
Analysts Have Conflicting Sentiments on These Healthcare Companies: Deciphera Pharmaceuticals (DCPH) and Shockwave Medical (SWAV)
TipRanksApr 8 20:40
Barclays Keeps Their Sell Rating on Deciphera Pharmaceuticals (DCPH)
TipRanksFeb 21 19:51
Buy Rating Reaffirmed for Deciphera Pharmaceuticals on Strong Q4 Performance and Promising Drug Prospects
TipRanksFeb 7 21:31
Deciphera Pharmaceuticals (DCPH) Gets a Sell From Barclays
TipRanksFeb 7 18:19
Analysts Are Bullish on Top Healthcare Stocks: Deciphera Pharmaceuticals (DCPH), ACADIA Pharmaceuticals (ACAD)
TipRanksFeb 7 13:50
Deciphera Pharmaceuticals: Strong Buy Rating on Robust Financials and Promising Pipeline
TipRanksFeb 7 01:45
Deciphera Pharmaceuticals: Sustained Growth and Market Expansion Drive Buy Rating
TipRanksFeb 7 00:35
Piper Sandler Remains a Buy on Deciphera Pharmaceuticals (DCPH)
TipRanksJan 23 03:23
Stifel Nicolaus Sticks to Their Buy Rating for Deciphera Pharmaceuticals (DCPH)
TipRanksJan 5 20:45
JP Morgan Reinstates Neutral on Deciphera Pharmaceuticals, Announces $14 Price Target
BenzingaNov 20, 2023 21:17
Deciphera Pharmaceuticals Analyst Ratings
BenzingaNov 20, 2023 21:16
Analysts Offer Insights on Healthcare Companies: Deciphera Pharmaceuticals (DCPH) and Ocular Therapeutix (OCUL)
TipRanksNov 6, 2023 13:30
Promising Clinical Trial Results and Financial Performance Lead to Deciphera Pharmaceuticals' Buy Rating Upgrade
TipRanksNov 2, 2023 13:21
No Data
No Data